• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用在线磁共振图像引导评估淋巴结寡转移立体定向放射治疗的计划适应策略

Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance.

作者信息

Winkel Dennis, Bol Gijsbert H, Werensteijn-Honingh Anita M, Kiekebosch Ilse H, van Asselen Bram, Intven Martijn P W, Eppinga Wietse S C, Raaymakers Bas W, Jürgenliemk-Schulz Ina M, Kroon Petra S

机构信息

Department of Radiotherapy, University Medical Center, Utrecht, the Netherlands.

出版信息

Phys Imaging Radiat Oncol. 2019 Mar 1;9:58-64. doi: 10.1016/j.phro.2019.02.003. eCollection 2019 Jan.

DOI:10.1016/j.phro.2019.02.003
PMID:33458426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7807584/
Abstract

BACKGROUND AND PURPOSE

Recent studies have shown that the use of magnetic resonance (MR) guided online plan adaptation yields beneficial dosimetric values and reduces unplanned violations of the dose constraints for stereotactic body radiation therapy (SBRT) of lymph node oligometastases. The purpose of this R-IDEAL stage 0 study was to determine the optimal plan adaptation approach for MR-guided SBRT treatment of lymph node oligometastases.

MATERIALS AND METHODS

Using pre-treatment computed tomography (CT) and repeated MR data from five patients with in total 17 pathological lymph nodes, six different methods of plan adaptation were performed on the daily MRI and contours. To determine the optimal plan adaptation approach for treatment of lymph node oligometastases, the adapted plans were evaluated using clinical dose criteria and the time required for performing the plan adaptation.

RESULTS

The average time needed for the different plan adaptation methods ranged between 11 and 119 s. More advanced adaptation methods resulted in more plans that met the clinical dose criteria [range, 0-16 out of 17 plans]. The results show a large difference between target coverage achieved by the different plan adaptation methods.

CONCLUSION

Results suggested that multiple plan adaptation methods, based on plan adaptation on the daily anatomy, were feasible for MR-guided SBRT treatment of lymph node oligometastases. The most advanced method, in which a full online replanning was performed by segment shape and weight optimization after fluence optimization, yielded the most favourable dosimetric values and could be performed within a time-frame acceptable (<5 min) for MR-guided treatment.

摘要

背景与目的

近期研究表明,在淋巴结寡转移灶的立体定向体部放射治疗(SBRT)中,使用磁共振(MR)引导的在线计划调整可产生有益的剂量学值,并减少剂量约束的意外违反情况。本R-IDEAL 0期研究的目的是确定MR引导下SBRT治疗淋巴结寡转移灶的最佳计划调整方法。

材料与方法

利用5例患者共17个病理淋巴结的治疗前计算机断层扫描(CT)和重复的MR数据,对每日MRI和轮廓进行6种不同的计划调整方法。为确定治疗淋巴结寡转移灶的最佳计划调整方法,使用临床剂量标准和执行计划调整所需时间对调整后的计划进行评估。

结果

不同计划调整方法所需的平均时间在11至119秒之间。更先进的调整方法产生了更多符合临床剂量标准的计划[范围,17个计划中的0至16个]。结果显示不同计划调整方法实现的靶区覆盖存在很大差异。

结论

结果表明,基于每日解剖结构进行计划调整的多种计划调整方法对于MR引导下SBRT治疗淋巴结寡转移灶是可行的。最先进的方法是在通量优化后通过节段形状和权重优化进行完全在线重新计划,该方法产生了最有利的剂量学值,并且可以在MR引导治疗可接受的时间范围内(<5分钟)完成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/b23e106932db/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/ee98fa89dab0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/37a1ba2f7642/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/705c94567905/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/da07fa08cdc7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/2ef8468b8699/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/2d988b5ac6c5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/b23e106932db/fx2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/ee98fa89dab0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/37a1ba2f7642/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/705c94567905/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/da07fa08cdc7/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/2ef8468b8699/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/2d988b5ac6c5/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/15e1/7807584/b23e106932db/fx2.jpg

相似文献

1
Evaluation of plan adaptation strategies for stereotactic radiotherapy of lymph node oligometastases using online magnetic resonance image guidance.使用在线磁共振图像引导评估淋巴结寡转移立体定向放射治疗的计划适应策略
Phys Imaging Radiat Oncol. 2019 Mar 1;9:58-64. doi: 10.1016/j.phro.2019.02.003. eCollection 2019 Jan.
2
Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.基于目标覆盖和剂量标准的评价:与常规 CBCT-直线加速器治疗相比,首个临床 1.5TMR-直线加速器 SBRT 治疗淋巴结寡转移的疗效。
Radiother Oncol. 2020 May;146:118-125. doi: 10.1016/j.radonc.2020.02.011. Epub 2020 Mar 6.
3
Dosimetric feasibility of hypofractionation for SBRT treatment of lymph node oligometastases on the 1.5T MR-linac.1.5TMR 直线加速器立体定向消融放疗治疗淋巴结寡转移灶的分割剂量可行性。
Radiother Oncol. 2021 Jan;154:243-248. doi: 10.1016/j.radonc.2020.09.020. Epub 2020 Sep 16.
4
Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.基于 1.5TMR- Linac 的立体定向体部放疗淋巴结寡转移灶在线计划校正的剂量学模拟研究
Acta Oncol. 2018 Dec;57(12):1705-1712. doi: 10.1080/0284186X.2018.1512152. Epub 2018 Oct 3.
5
Adaptive radiotherapy: The Elekta Unity MR-linac concept.自适应放疗:医科达Unity MR直线加速器概念
Clin Transl Radiat Oncol. 2019 Apr 2;18:54-59. doi: 10.1016/j.ctro.2019.04.001. eCollection 2019 Sep.
6
Individual lymph nodes: "See it and Zap it".单个淋巴结:“看到即清除”。
Clin Transl Radiat Oncol. 2019 Mar 30;18:46-53. doi: 10.1016/j.ctro.2019.03.004. eCollection 2019 Sep.
7
Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.模拟磁共振引导肝脏立体定向体部放疗的日常计划适应性调整。
Acta Oncol. 2021 Feb;60(2):260-266. doi: 10.1080/0284186X.2020.1840625. Epub 2020 Nov 10.
8
Dosimetric benefit of online treatment plan adaptation in stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer.在线治疗计划调整在立体定向超分割磁共振引导下的局部前列腺癌放疗中的剂量学益处。
Front Oncol. 2024 Feb 15;14:1308406. doi: 10.3389/fonc.2024.1308406. eCollection 2024.
9
Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.磁共振引导与传统放疗流程对淋巴结寡转移立体定向体部放疗中危及器官剂量的影响。
Phys Imaging Radiat Oncol. 2022 Jun 30;23:66-73. doi: 10.1016/j.phro.2022.06.011. eCollection 2022 Jul.
10
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastases.1.5TMR 引导的每日自适应 SBRT 治疗腹盆部淋巴结寡转移瘤可减轻肠道蠕动的每日变化。
J Cancer Res Clin Oncol. 2021 Nov;147(11):3269-3277. doi: 10.1007/s00432-021-03739-8. Epub 2021 Jul 15.

引用本文的文献

1
Treatment planning evaluation and experimental validation of the magnetic resonance-based intrafraction drift correction.基于磁共振的分次内漂移校正的治疗计划评估与实验验证。
Phys Imaging Radiat Oncol. 2024 Apr 21;30:100580. doi: 10.1016/j.phro.2024.100580. eCollection 2024 Apr.
2
Benchmarking daily adaptation using fully automated radiotherapy treatment plan optimization for rectal cancer.使用全自动放射治疗计划优化对直肠癌进行每日适应性的基准测试。
Phys Imaging Radiat Oncol. 2022 Aug 18;24:7-13. doi: 10.1016/j.phro.2022.08.006. eCollection 2022 Oct.
3
Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.

本文引用的文献

1
Analysis of intra-fraction prostate motion and derivation of duration-dependent margins for radiotherapy using real-time 4D ultrasound.使用实时4D超声分析分次放疗期间前列腺运动并推导与时间相关的边界。
Phys Imaging Radiat Oncol. 2018 Mar 28;5:102-107. doi: 10.1016/j.phro.2018.03.008. eCollection 2018 Jan.
2
Simulated dosimetric impact of online replanning for stereotactic body radiation therapy of lymph node oligometastases on the 1.5T MR-linac.基于 1.5TMR- Linac 的立体定向体部放疗淋巴结寡转移灶在线计划校正的剂量学模拟研究
Acta Oncol. 2018 Dec;57(12):1705-1712. doi: 10.1080/0284186X.2018.1512152. Epub 2018 Oct 3.
3
磁共振引导与传统放疗流程对淋巴结寡转移立体定向体部放疗中危及器官剂量的影响。
Phys Imaging Radiat Oncol. 2022 Jun 30;23:66-73. doi: 10.1016/j.phro.2022.06.011. eCollection 2022 Jul.
4
Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT.使用未编辑的基于CT的DIR传播自动轮廓对胰腺癌SBRT在线ART的影响。
Front Oncol. 2022 Jun 8;12:910792. doi: 10.3389/fonc.2022.910792. eCollection 2022.
5
Clinical implementation and feasibility of long-course fractionated MR-guided chemoradiotherapy for patients with esophageal cancer: An R-IDEAL stage 1b/2a evaluation of technical innovation.食管癌患者长疗程分次磁共振引导放化疗的临床实施与可行性:技术创新的R-IDEAL 1b/2a期评估
Clin Transl Radiat Oncol. 2022 Mar 17;34:82-89. doi: 10.1016/j.ctro.2022.03.008. eCollection 2022 May.
6
Clinical Implementation and Initial Experience With a 1.5 Tesla MR-Linac for MR-Guided Radiation Therapy for Gynecologic Cancer: An R-IDEAL Stage 1 and 2a First in Humans Feasibility Study of New Technology Implementation.1.5T 磁共振直线加速器用于妇科癌症磁共振引导放射治疗的临床应用及初步经验:新技术实施的 R-IDEAL 1 期和 2a 期人体首次可行性研究。
Pract Radiat Oncol. 2022 Jul-Aug;12(4):e296-e305. doi: 10.1016/j.prro.2022.03.002. Epub 2022 Mar 9.
7
Analysis of online plan adaptation for 1.5T magnetic resonance-guided stereotactic body radiotherapy (MRgSBRT) of prostate cancer.分析 1.5T 磁共振引导立体定向体部放射治疗(MRgSBRT)前列腺癌的在线计划自适应。
J Cancer Res Clin Oncol. 2023 Feb;149(2):841-850. doi: 10.1007/s00432-022-03950-1. Epub 2022 Feb 24.
8
Dose accumulation of daily adaptive plans to decide optimal plan adaptation strategy for head-and-neck patients treated with MR-Linac.根据头颈部患者接受 MR-Linac 治疗的每日自适应计划的剂量积累,确定最佳计划自适应策略。
Med Dosim. 2022;47(1):103-109. doi: 10.1016/j.meddos.2021.08.005. Epub 2021 Oct 28.
9
Online Magnetic Resonance-Guided Radiotherapy (oMRgRT) for Gynecological Cancers.用于妇科癌症的在线磁共振引导放射治疗(oMRgRT)
Front Oncol. 2021 Aug 27;11:628131. doi: 10.3389/fonc.2021.628131. eCollection 2021.
10
Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy.每日治疗计划自适应在前列腺癌立体定向体放射治疗中的剂量学优势。
Radiat Oncol. 2021 Aug 4;16(1):145. doi: 10.1186/s13014-021-01872-9.
Locoregional control and survival after lymph node SBRT in oligometastatic disease.
寡转移疾病中淋巴结 SBRT 的局部区域控制和生存。
Clin Exp Metastasis. 2018 Oct;35(7):625-633. doi: 10.1007/s10585-018-9922-x. Epub 2018 Jul 11.
4
Role of Daily Plan Adaptation in MR-Guided Stereotactic Ablative Radiation Therapy for Adrenal Metastases.每日计划自适应在 MR 引导下肾上腺转移灶立体定向消融放疗中的作用。
Int J Radiat Oncol Biol Phys. 2018 Oct 1;102(2):426-433. doi: 10.1016/j.ijrobp.2018.06.002. Epub 2018 Jun 11.
5
Evaluation of Online Plan Adaptation Strategies for the 1.5T MR-linac Based on "First-In-Man" Treatments.基于“首例人体”治疗对1.5T磁共振直线加速器在线计划自适应策略的评估
Cureus. 2018 Apr 5;10(4):e2431. doi: 10.7759/cureus.2431.
6
Stereotactic Magnetic Resonance-guided Online Adaptive Radiotherapy for Oligometastatic Breast Cancer: A Case Report.
Cureus. 2018 Mar 26;10(3):e2368. doi: 10.7759/cureus.2368.
7
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?磁共振成像引导自适应放疗:前列腺治疗的“游戏规则改变者”?
Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):361-373. doi: 10.1016/j.ijrobp.2017.10.020. Epub 2017 Oct 26.
8
Phase I trial of stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of oligometastatic or unresectable primary malignancies of the abdomen.立体定向磁共振引导在线自适应放疗(SMART)治疗腹部寡转移或不可切除的原发性恶性肿瘤的 I 期临床试验。
Radiother Oncol. 2018 Mar;126(3):519-526. doi: 10.1016/j.radonc.2017.11.032. Epub 2017 Dec 23.
9
Oligometastases in prostate cancer : Metabolic response in follow-up PSMA-PET-CTs after hypofractionated IGRT.前列腺癌寡转移灶:低分割 IGRT 后 PSMA-PET-CT 随访中的代谢反应。
Strahlenther Onkol. 2018 Apr;194(4):318-324. doi: 10.1007/s00066-017-1239-1. Epub 2017 Nov 27.
10
First patients treated with a 1.5 T MRI-Linac: clinical proof of concept of a high-precision, high-field MRI guided radiotherapy treatment.首例接受1.5T磁共振直线加速器治疗的患者:高精度、高场强磁共振引导放射治疗的临床概念验证。
Phys Med Biol. 2017 Nov 14;62(23):L41-L50. doi: 10.1088/1361-6560/aa9517.